A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds
NCT ID: NCT05106751
Last Updated: 2023-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
104 participants
INTERVENTIONAL
2021-10-21
2023-04-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Classic Plus Versus YVOIRE Classic in Nasolabial Fold Injection
NCT02340091
A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Volume Plus Versus YVOIRE Volume in Nasolabial Fold Injection
NCT02340078
Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s
NCT02661737
Effectiveness and Safety of YVOIRE Y-Solution 540
NCT04855188
Clinical Study to Evaluate the Correction of Wrinkles and Folds and Safety of YVOIRE Classic Versus Restylane in Nasolabial Fold Intradermal Injection
NCT03738020
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
YVOIRE Classic plus
Hyaluronic acid dermal filler
Hyaluronic acid dermal filler used for facial volume or wrinkle correction
Restylane Lidocaine
Hyaluronic acid dermal filler
Hyaluronic acid dermal filler used for facial volume or wrinkle correction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyaluronic acid dermal filler
Hyaluronic acid dermal filler used for facial volume or wrinkle correction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2 or 3 of the 5-point (0-4) NLFRS (Nasolabial Fold Rating Scale).
* Agree to use proper contraception as guided in the protocol.
* Signed for Informed Consent.
Exclusion Criteria
* have undergone facial plastic surgery of the lower face and nasolabial region within 12 weeks
* have undergone semi-permanent filler in lower face
* have undergone temporary dermal filler treatment in the lower two-thirds of face within 12 months
* Have undergone facial tissue augmentation or facial treatment with fat or botulinum injections in the lower two-thirds of face
* Have undergone mesotherapy or cosmetic procedures in face or neck within 6 months
* have used any over-the-counter anti-wrinkle products or prescription anti-wrinkle medicines for the nasolabial folds within 28 days
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LG Chem
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
LG Chem investigational site 01
Darmstadt, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LG-HACL033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.